__24K27xDIr9.png)
AM-DV-01 has been proven that can effectively reduce the ADE phenomenon
__24K27c2zcI.png)
AM-168 acting against HER3 has great potential as a novel agent for the treatment of solid tumors that bear resistance to EGFR or HER2.
__24K27h7Sh6.png)
SB001 neutralizing human antibodies targeting the RBD domain of SARS-CoV-2 spike protein have potential in prophylactic or therapeutic applications for COVID-19.
AcadeMab
CONTACT US
Verification
Click the numbers in sequence.
academab.com may set and access academab.com cookies on your computer. Cookies are used to provide our system with the basic information to provide the services you are requesting. Cookies can be cleared at any time from your internet browser settings.
Privacy preference center
academab.com may set and access academab.com cookies on your computer. Cookies are used to provide our system with the basic information to provide the services you are requesting. Cookies can be cleared at any time from your internet browser settings.
Manage Consent Settings
Necessary Cookies
網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作（即服務請求）來設置這些 Cookie，如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie，但可能會導致某些網站功能無法工作。
